Anna Dąbrowska

Anna Dąbrowska

Auto-generated profile, based on publicly available information

Anna Dąbrowska

Student Scientific Circle of Oncology and Radiotherapy, Medical University of Gdansk, 80-210 Gdansk, Poland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ADAnna Dąbrowska
Anna Dąbrowska
MGMagdalena Grubba
Magdalena Grubba
ABAmar Balihodzic
Amar Balihodzic
OSOlga Szot
Olga Szot
BSBartosz Sobocki
Bartosz Sobocki
APAdrian Perdyan
Adrian Perdyan
Despite tremendous progress in cancer treatment in recent years, treatment resistance is still a major challenge for a great number of patients. One of the main causes is regulatory T lymphocytes (Tregs), which suppress excessive inflammatory responses via the secretion of immunosuppressive cytokines and upregulate the immune checkpoints. Their abundance causes an immunosuppressive reprogramming of the tumor environment, which is ideal for tumor growth and drug inefficiency. Hence, regiments that can regain tumor immunogenicity are a promising strategy to overcome Tregs-mediated drug resistance. However, to develop effective therapeutic regimens, it is essential to understand the molecular mechanisms of Treg-mediated resistance. In this article, we gathered a comprehensive summary of the current knowledge on molecular mechanisms and the role of Tregs in cancer treatment resistance, including cancer immunotherapy, targeted therapy, chemotherapy, and radiotherapy.

4 July 2023 in Cancers
Verified
Journal Article
Open access
PDF file
APAdrian Perdyan
Adrian Perdyan
BSBartosz Sobocki
Bartosz Sobocki
ABAmar Balihodzic
Amar Balihodzic
ADAnna Dąbrowska
Anna Dąbrowska
JKJustyna Kacperczyk
Justyna Kacperczyk
JRJacek Rutkowski
Jacek Rutkowski
Despite a great success of immunotherapy in cancer treatment, a great number of patients will become resistant. This review summarizes recent reports on immune checkpoint inhibitor retreatment or rechallenge in order to overcome primary resistance. The systematic review was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The search was performed using PubMed, Web of Science and Scopus. In total, 31 articles were included with a total of 812 patients. There were 16 retreatment studies and 13 rechallenge studies. We identified 15 studies in which at least one parameter (overall response rate or disease control rate) improved or was stable at secondary treatment. Interval treatment, primary response to and the cause of cessation for the first immune checkpoint inhibitors seem to be promising predictors of secondary response. However, high heterogeneity of investigated cohorts and lack of reporting guidelines are limiting factors for current in-depth analysis.

23 May 2023 in Medycyna Ogólna i Nauki o Zdrowiu
Verified
Journal Article
Open access
ZCZuzanna Chmielewska
Zuzanna Chmielewska
Krzysztof SobczakKrzysztof Sobczak
Krzysztof Sobczak
PDPaulina Dąbrowska
Paulina Dąbrowska
ADAnna Dąbrowska
Anna Dąbrowska
JŚJulia Świechowska
Julia Świechowska
MDMagdalena Dorobek
Magdalena Dorobek
Introduction and objective: The COVID-19 pandemic caused necessary changes to the health care system in terms of the organization and treatment of patients. Remote forms of medical consultations were widely introduced to minimize the risk of viral transmission. The aim of the study was to...

16 September 2020 in Acta Haematologica Polonica
Verified
Journal Article
Open access
PDF file
EDEwa Demidowicz
Ewa Demidowicz
NBNatalia Bartoszewicz
Natalia Bartoszewicz
KCKrzysztof Czyzewski
Krzysztof Czyzewski
JCJoanna Cisek
Joanna Cisek
ADAnna Dąbrowska
Anna Dąbrowska
JSJan Styczyński
Jan Styczyński
Introduction: Leukemia belong to 31% of all childhood malignancies. Acute lymphoblastic leukemia (ALL) is the most frequent type of pediatric leukemia accounting for 80–85% of all cases. Progress in diagnostics and therapy of leukemia is dependent on international cooperation. The objective of the study was the analysis of non-hematological toxicity during intensive chemotherapy according to two consecutive intercontinental protocols.Patients and methods: A total number of 210 children diagnosed for ALL who were treated in single center between 2002 and 2018 were divided in two groups defined by therapeutic protocol: ALL IC-BFM 2002 (group 1) and ALL IC-BFM 2009 (group 2). Data were entered prospectively from 2002 into international ALL IC-BFM 2002 and ALL IC-BFM 2009 registry. Non-hematological toxicity was analyzed according to the criteria followed in protocols, compatible with CTCAE criteria.Results: The most frequent toxicities included hepatic toxicity with transaminitis and hyperbilirubinemia, infections, oral mucositis and gut toxicity with vomiting, and/or diarrhea. Non-hematological toxicity episodes calculated as a ratio per patient were comparably often observed in both the groups; however, the distribution was different. There were more grade III and less grade II toxicities. This was mainly related to significant increase in the rates of infections and transaminitis. However, there was a significant decrease in vomiting and central and peripheral neurotoxicity.Conclusions: Intensive treatment of ALL is burdened with frequent severe toxic and infectious complications. Further progress in therapy of pediatric ALL is dependent on sophisticated supportive therapy and very well experienced and knowledgeable therapeutic team.

9 July 2024 in Cureus
Verified
Journal Article
Open access
PDF file
ADAnna Dąbrowska
Anna Dąbrowska
WMWiktoria Malik
Wiktoria Malik
DCDorota Czachor
Dorota Czachor
WJWeronika Jarych
Weronika Jarych
AWAnna Wściślak
Anna Wściślak
PPPiotr Pałczyński
Piotr Pałczyński
Introduction: Management of injuries, especially in life-threatening situations, is critical to morbidity and mortality for trauma patients. The qualifications of medical staff and students in medicine, emergency medical services, and nursing help to ensure consistent, high-quality care for patients. The study aimed to assess the knowledge of our staff and learners in the management of trauma patients. Material and methods: The study was carried out using a proprietary research tool consisting of 47 questions, including six independent variables. The knowledge assessment tool has been divided into five categories according to the degree of difficulty. The questions have been created based on the current guidelines of the ERC 2021, ITLS, PTLS, and TCCC. Results: The study included 295 subjects (medical students, nursing students, students of emergency medical services, physicians, paramedics, and nurses). The vast majority of respondents (79.7%) have never participated in a certified trauma course. Respondents could obtain a total of 117 points for answering all questions. The highest score was 111 points, and the lowest was 26 points. The average score was 63 points. Paramedics received the highest average score of 78 points. The question with the smallest number of correct answers concerned the priority procedure in the case of an electric shock victim. Conclusion: Better training in trauma patient management is needed for both current medical staff and students. A certified trauma course is a good source of knowledge and skills, but it would need to be repeated periodically. This would ensure an increase in the competence of medical staff involved in the care of trauma patients.

4 January 2024 in Nowotwory. Journal of Oncology
Verified
Journal Article
Open access
PDF file
ADAnna Dąbrowska
Anna Dąbrowska
APAdrian Perdyan
Adrian Perdyan
BSBartosz K. Sobocki
Bartosz K. Sobocki
JRJacek Rutkowski
Jacek Rutkowski
Diagnosis of neoplasms during pregnancy and establishing a treatment schedule that is safe for both mother and fetus is problematic. This review summarizes knowledge about the problems associated with cervical cancer during pregnancy and current recommendations for diagnosis and treatment. The systematic review was performed according to PRISMA guidelines. The search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Seven articles on 317 pregnant women with cervical cancer were included. Stage of disease, gestational age at diagnosis, treatment in pregnancy, type of delivery, gestational age of delivery, treatment after delivery, follow-up and main conclusion were analyzed. The rare phenomenon of neoplasms during pregnancy, as well as a limited research, do not allow for the development of clear guidelines for the treatment of cervical cancer in pregnant women. It is warrant to address discussed problems in future clinical research to provide the best care for pregnant cancer patients. Diagnosis of neoplasms during pregnancy and establishing a treatment schedule that is safe for both mother and fetus is problematic. This review summarizes knowledge about the problems associated with cervical cancer during pregnancy and current recommendations for diagnosis and treatment. The systematic review was performed according to PRISMA guidelines. The search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Seven articles on 317 pregnant women with cervical cancer were included. Stage of disease, gestational age at diagnosis, treatment in pregnancy, type of delivery, gestational age of delivery, treatment after delivery, follow-up and main conclusion were analyzed. The rare phenomenon of neoplasms during pregnancy, as well as a limited research, do not allow for the development of clear guidelines for the treatment of cervical cancer in pregnant women. It is warrant to address discussed problems in future clinical research to provide the best care for pregnant cancer patients.